Interleukin‐22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma. Issue 3 (13th December 2013) - Waidmann, Oliver; Kronenberger, Bernd; Scheiermann, Patrick; Köberle, Verena; Mühl, Heiko; Piiper, Albrecht